
Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs
Author(s) -
Jiaye Tao,
Heping Wang,
Wenjian Wang,
Na Mi,
Wei Zhang,
Qiu-Jia Wen,
Jiajing Ouyang,
Xinyun Liang,
Min Chen,
Wentao Guo,
Guoming Li,
Jun Li,
Han-ning Zhao,
Xin Wang,
Xuemeng Li,
Shengjun Feng,
Xinguang Liu,
Zhiwei He,
Zuguo Zhao
Publication year - 2022
Publication title -
plos computational biology/plos computational biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.628
H-Index - 182
eISSN - 1553-7358
pISSN - 1553-734X
DOI - 10.1371/journal.pcbi.1010343
Subject(s) - oseltamivir , neuraminidase , neuraminidase inhibitor , influenza a virus , binding site , chemistry , virology , virus , biology , biochemistry , medicine , covid-19 , infectious disease (medical specialty) , disease , pathology